Better Features for Biobanks

January 16, 2024 1:33 pm | by Mike May, PhD | Articles | Comments

Collecting specimens in biobanks provides little value unless the samples can be easily used. As Mark A Collins, PhD, director of marketing at BioFortis, says, “People have invested a lot of money in biobanks and the specimens in them. Now, they are looking to best leverage those specimens to drive clinical research, personalized medicine and clinical trials.”